ATE290866T1 - Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten - Google Patents
Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheitenInfo
- Publication number
- ATE290866T1 ATE290866T1 AT99965071T AT99965071T ATE290866T1 AT E290866 T1 ATE290866 T1 AT E290866T1 AT 99965071 T AT99965071 T AT 99965071T AT 99965071 T AT99965071 T AT 99965071T AT E290866 T1 ATE290866 T1 AT E290866T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- neurotrophic factor
- ophthalmic diseases
- factor stimulators
- neurodegenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11098398P | 1998-12-03 | 1998-12-03 | |
| PCT/US1999/028385 WO2000032197A1 (en) | 1998-12-03 | 1999-12-01 | Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE290866T1 true ATE290866T1 (de) | 2005-04-15 |
Family
ID=22335984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99965071T ATE290866T1 (de) | 1998-12-03 | 1999-12-01 | Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1135134B1 (de) |
| JP (1) | JP2002531405A (de) |
| KR (1) | KR100688137B1 (de) |
| CN (1) | CN1325308A (de) |
| AR (1) | AR022685A1 (de) |
| AT (1) | ATE290866T1 (de) |
| AU (1) | AU769290B2 (de) |
| BR (1) | BR9915803A (de) |
| CA (1) | CA2353527C (de) |
| DE (1) | DE69924284T2 (de) |
| ES (1) | ES2237196T3 (de) |
| HK (1) | HK1038510B (de) |
| PT (1) | PT1135134E (de) |
| TW (1) | TWI246421B (de) |
| WO (1) | WO2000032197A1 (de) |
| ZA (1) | ZA200102714B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002004452A2 (en) * | 2000-07-07 | 2002-01-17 | Neotherapeutics, Inc. | Methods for treatment of disease-induced peripheral neuropathy and related conditions |
| US20020156277A1 (en) * | 2001-04-20 | 2002-10-24 | Fick David B. | Synthesis and methods of use of purine analogues and derivatives |
| CN1549718A (zh) * | 2001-08-29 | 2004-11-24 | 爱尔康公司 | 化合物用于治疗由lasik和其它眼睛手术或创伤后角膜神经损伤而导致的情况的应用 |
| EP1666068A4 (de) * | 2003-09-24 | 2010-08-04 | Santen Pharmaceutical Co Ltd | Mittel zur behandlung von augenerkrankungen mit verletzungen des sehnervs |
| WO2006054513A1 (ja) * | 2004-11-19 | 2006-05-26 | Kissei Pharmaceutical Co., Ltd. | 神経因性疼痛の予防又は治療剤 |
| EP1754474A1 (de) * | 2005-02-02 | 2007-02-21 | Eucro European Contract Research GmbH & Co. KG | Verwendung von S-Clenbuterol |
| JPWO2006098292A1 (ja) | 2005-03-15 | 2008-08-21 | 小野薬品工業株式会社 | 眼疾患治療剤 |
| PT2605769T (pt) | 2010-08-16 | 2016-11-02 | Santhera Pharmaceuticals (Schweiz) Ag | Derivados benziquinona como modeladores da função mitocondrial |
| ES2841993T3 (es) * | 2012-10-23 | 2021-07-12 | Nicox Sa | Compuestos donantes de óxido nítrico a base de quinona para uso oftálmico |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH059114A (ja) * | 1990-08-29 | 1993-01-19 | Takeda Chem Ind Ltd | 糖尿病性合併症の予防・治療剤 |
| US5780450A (en) * | 1995-11-21 | 1998-07-14 | Alcon Laboratories, Inc. | Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage |
| US5641749A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
| US5641750A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
| WO1998010785A1 (fr) * | 1996-09-13 | 1998-03-19 | Advanced Medicine Research Institute | Compositions ophtalmiques de facteurs neurotrophiques, remedes pour troubles fonctionnels du nerf optique et procede de traitement de tels troubles |
| AU4582797A (en) * | 1996-09-13 | 1998-04-02 | Regents Of The University Of California, The | Methods for treatment of retinal diseases |
| JPH10218787A (ja) * | 1997-02-06 | 1998-08-18 | Akio Okamoto | 神経栄養因子による眼科用組成物 |
-
1999
- 1999-11-23 TW TW088120454A patent/TWI246421B/zh not_active IP Right Cessation
- 1999-12-01 KR KR1020017003178A patent/KR100688137B1/ko not_active IP Right Cessation
- 1999-12-01 EP EP99965071A patent/EP1135134B1/de not_active Expired - Lifetime
- 1999-12-01 AU AU31066/00A patent/AU769290B2/en not_active Ceased
- 1999-12-01 DE DE69924284T patent/DE69924284T2/de not_active Expired - Lifetime
- 1999-12-01 AT AT99965071T patent/ATE290866T1/de active
- 1999-12-01 CA CA002353527A patent/CA2353527C/en not_active Expired - Fee Related
- 1999-12-01 WO PCT/US1999/028385 patent/WO2000032197A1/en not_active Application Discontinuation
- 1999-12-01 ES ES99965071T patent/ES2237196T3/es not_active Expired - Lifetime
- 1999-12-01 CN CN99813086A patent/CN1325308A/zh active Pending
- 1999-12-01 JP JP2000584892A patent/JP2002531405A/ja active Pending
- 1999-12-01 PT PT99965071T patent/PT1135134E/pt unknown
- 1999-12-01 BR BR9915803-5A patent/BR9915803A/pt not_active Application Discontinuation
- 1999-12-02 AR ARP990106130A patent/AR022685A1/es unknown
-
2001
- 2001-04-03 ZA ZA200102714A patent/ZA200102714B/en unknown
-
2002
- 2002-01-08 HK HK02100111.2A patent/HK1038510B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200102714B (en) | 2002-06-03 |
| DE69924284T2 (de) | 2005-08-04 |
| CA2353527A1 (en) | 2000-06-08 |
| PT1135134E (pt) | 2005-05-31 |
| KR20010075055A (ko) | 2001-08-09 |
| WO2000032197A1 (en) | 2000-06-08 |
| CN1325308A (zh) | 2001-12-05 |
| BR9915803A (pt) | 2001-08-21 |
| AU769290B2 (en) | 2004-01-22 |
| KR100688137B1 (ko) | 2007-03-09 |
| JP2002531405A (ja) | 2002-09-24 |
| DE69924284D1 (de) | 2005-04-21 |
| CA2353527C (en) | 2007-11-06 |
| HK1038510A1 (en) | 2002-03-22 |
| HK1038510B (zh) | 2005-05-20 |
| TWI246421B (en) | 2006-01-01 |
| ES2237196T3 (es) | 2005-07-16 |
| AU3106600A (en) | 2000-06-19 |
| EP1135134B1 (de) | 2005-03-16 |
| EP1135134A1 (de) | 2001-09-26 |
| AR022685A1 (es) | 2002-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69936335D1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| ATE271038T1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
| DE69722681D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen | |
| DE59711321D1 (de) | Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen | |
| ATE308997T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
| DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| DE69836752D1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
| DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
| DE69922914D1 (de) | Stimulationssystem zur Behandlung von Erkrankungen bezüglich des Magenspeiseröhrenreflux | |
| DE69927823T2 (de) | Hydrogel für die therapeutische behandlung von aneurysmas | |
| DE69509544D1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
| ATE292134T1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| DE69807466D1 (de) | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten | |
| ATE290866T1 (de) | Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
| DE59704933D1 (de) | Verwendung von PHMB zur Behandlung von Tumorerkrankungen | |
| DE60018200D1 (de) | Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen | |
| DE69822297D1 (de) | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten | |
| DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| ATE230741T1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
| ATE433323T1 (de) | Verwendung von erythropoietin zur behandlung von primärer hämochromatosen | |
| DE69918541D1 (de) | Verwendung von nmda antagonisten zur behandlung des reizkolons |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1135134 Country of ref document: EP |